Clonazepam in panic disorder;Clonazepam no transtorno de pânico

Jornal Brasileiro de Psiquiatria

Volumn 50, Issue 11-12, 2001, Pages 407-413

  Nardi, Antônio Egidio ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Benzodiazepine; Clonazepam; Panic disorder; Treatment

Indexed keywords

ALCOHOL; ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CARBON DIOXIDE; CLONAZEPAM; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 2 RECEPTOR;

AMNESIA; ATAXIA; CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ALCOHOL INTERACTION; DRUG DEPENDENCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENCY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FRONTAL CORTEX; GABAERGIC SYSTEM; HUMAN; PANIC; REVIEW; RISK BENEFIT ANALYSIS; SEROTONIN UPTAKE; SOMNOLENCE;

EID: 19544389194     PISSN: 00472085     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Schatzberg, A.F. Overview of anxiety disorders: prevalence, biology, course, and treatment. J. Clin. Psychiatry, 52(suppl.): 5-9, 1991.
2. Weissman, M.M. The epidemiology and genetics of panic disorder. Clin. Neuropharmacol. 15(suppl. 1): 18-9, 1992.
3. Almeida Filho, N. et al. Estudo multicêntrico de morbidade psiquiátrica em áreas urbanas brasileiras (Brasília, Sáo Paulo e Porto Alegre). Revista ABP-APAL, 14: 93-104, 1992.
4. Klein, D.F. Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia, 5: 397-408, 1964.
5. Zohar, J. & Westenberg, H.G. Anxiety disorders: a review of tricyclic antidepressants and serotonin reuptake inhibitors. Acta. Psychiatr. Scand., 403: 39-49, 2000.
6. Chouinard, G. et al. Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study. Psychopharmacology, 77: 229-33, 1982.
7. Fontaine, R. & Chouinard, G. Antipanic effects of clonazepam (letter). Am. J. Psychiatry, 141: 149, 1984.
8. Ballenger, J.C. et al. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short term treatment. Arch. Gen. Psychiatry, 45: 413-22, 1988.
9. Marks, I.M. et al. The efficacy of alprazolam in panic disorder and agoraphobia: a critique of recent reports. Arch. Gen. Psychiatry, 46: 668-9, 1989.
10. Cohen, L.S. & Rosebaum, J.F. Clonazepam: new uses and potential problems. J. Clin. Psychiatry, 48(suppl.): 50-6, 1987.
11. Versiani, M. & Nardi, A.E. O tratamento do transtorno de pânico. J. Bras. Psiquiatr., 38: 301-10, 1989.
12. Fennessy, M.R. & Lee, J.R. The effect of benzodiazepines on brain amines of the mouse. Arch. Int. Pharmacodyn. Ther., 197: 37-44, 1972.
13. Fontaine, R. Clonazepam for panic disorders and agitation. Psychosomatics, 26(suppl.): 13-6, 1985.
14. Herman, J.B., Rosenbaum, J.F. & Brotman, A.W. The alprazolam to clonazepam switch for the treatment of panic disorder. J. Clin. Psychopharmacol., 7: 175-8, 1987.
15. Herman, J.B.; Brotman, A.W. & Rosenbaum, J.F. Rebound anxiety in panic disorder patients treated with short-acting benzodiazepines. J. Clin. Psychiatry, 48(suppl.): 22-6, 1987.
16. 2 inhalation-provoked panic in a patient with panic disorder. J. Clin. Psychiatry, 47: 475-6, 1986.
17. Tesar, G.E. & Rosenbaum, J.F. Successful use of clonazepam in patients with treatment-resistant panic disorder. J. Nerv. Ment. Dis., 174: 477-82, 1986.
18. Valença, A.M.; Nascimento, I. & Nardi, A.E. Smoking and panic disorder. Psychiatr Serv., 52(8): 1105-6, 2001.
19. Beauclair, L. et al. Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response. J. Clin. Psychopharmacol., 14: 111-8, 1994.
20. Svebak, S.; Cameron, A. & Levander, S. Clonazepam and imipramine in the treatment of panic attacks: a double-blind comparison of efficacy and side-effects. J. Clin. Psychiatry, 51(suppl.): 14-7, 1990.
21. Judd, F.K. & Burrows, G.D. Clonazepam in the treatment of panic disorder. Med. J. Aust, 145: 59, 1986.
22. Spier, S.A. et al. Treatment of panic disorder and agoraphobia with Clonazepam. J. Clin. Psychiatry, 47: 238-42, 1986.
23. Pollack, M.H. et al. Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up. J. Clin. Psychopharmacol., 6: 302-4, 1986.
24. Tesar, G.E. et al. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. J. Clin. Psychiatry, 52: 69-76, 1991.
25. Tesar, G.E. et al. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial, J. Clin. Psychiatry, 48(suppl.): 16-9, 1987.
26. Tesar, G.E. High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience. J. Clin. Psychiatry, 51(suppl.): 4-10, 1990.
27. Pollack, M.H. et al. Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder. J. Clin. Psychopharmacol., 13: 257-63, 1993.
28. Labbate, L.A. et al. The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma. J. Clin. Psychopharmacol., 14: 274-6, 1994.
29. Valença, A.M. et al. Double-blind clonazepam vs. placebo in panic disorder treatment. Arq. Neuropsiquiatr., 58: 1025-9, 2000.
30. 2 inhalation-provoked panic in a patient with panic disorder. J. Clin. Psychiatry, 47: 475-6, 1986.
31. Pols, H. et al. Attenuation of carbon dioxide-induced panic after Clonazepam treatment. Acta. Psychiatr. Scand., 84: 585-6, 1991.
32. Nardi, A.E. et al. Carbon dioxide induced panic attack and short term clonazepam treatment: preliminary study. Arq. Neuropsiquiatr., 57(2-B): 361-5, 1999.
33. Nardi, A.E. et al. Double-blind acute clonazepam in carbon dioxide induced panic attacks. Psychiatry Res., 94(2): 179-84, 2000.